Pharmacokinetic interaction study of novel combination of palbociclib and sorafenib for hepatocellular carcinoma in SD rats

This publication has 25 references indexed in Scilit:

• Quantitative analysis of PD 0332991 in mouse plasma using automated micro-sample processing and microbore liquid chromatography coupled with tandem mass spectrometry
  Journal of Chromatography B, 2011
• Quantitative analysis of PD 0332991 in xenograft mouse tumor tissue by a 96-well supported liquid extraction format and liquid chromatography/mass spectrometry
  Journal of Pharmaceutical and Biomedical Analysis, 2010
• Quantitation of sorafenib and its active metabolite sorafenib N-oxide in human plasma by liquid chromatography–tandem mass spectrometry
  Journal of Chromatography B, 2010
• Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry
  Journal of Chromatography B, 2009
• Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
  Journal of Clinical Oncology, 2009
• Liquid chromatography–tandem mass spectrometric assay for sorafenib and sorafenib–glucuronide in mouse plasma and liver homogenate and identification of the glucuronide metabolite
  Journal of Chromatography B, 2009
• Sorafenib in Advanced Hepatocellular Carcinoma
  New England Journal of Medicine, 2008
• Development of a rapid and sensitive LC–MS/MS assay for the determination of sorafenib in human plasma
  Journal of Pharmaceutical and Biomedical Analysis, 2008
• A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assay
  Journal of Chromatography B, 2007
• Small Molecule Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: An Update of Recent Developments
  Annals of Surgical Oncology, 2006